These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25535894)

  • 1. Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia.
    Setoyama T; Miyamoto S; Horimatsu T; Funakoshi T; Nikaido M; Kodama Y; Minamiguchi S; Yamabata T; Muto M; Chiba T
    Cancer Biol Ther; 2014; 15(12):1588-92. PubMed ID: 25535894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
    Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
    Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
    van Doorn J; van de Hoef W; Dullaart RP
    Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
    Daughaday WH; Kapadia M
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
    Nauck MA; Reinecke M; Perren A; Frystyk J; Berishvili G; Zwimpfer C; Figge AM; Flyvbjerg A; Lankisch PG; Blum WF; Klöppel G; Schmiegel W; Zapf J
    J Clin Endocrinol Metab; 2007 May; 92(5):1600-5. PubMed ID: 17299065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
    Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability of IGF-IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse.
    Setoyama T; Miyamoto S; Nikaido M; Muto M; Chiba T
    Growth Horm IGF Res; 2015 Oct; 25(5):227-31. PubMed ID: 26144570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Takano K; Asakawa-Yasumoto K; Shizume K; Demura H
    Endocr J; 1993 Feb; 40(1):111-9. PubMed ID: 7524924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
    Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
    Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
    Plikat K; Reichle A; Elmlinger MW; Schölmerich J
    Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
    Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
    Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rare Diagnosis After the Fall of a 96-Year-Old Woman: Doege-Potter Syndrome.
    Pincelli AI; Perotti M; Massariello F; Gatti A; Calella D; Cimino V; Haas J; Bellelli G; Mazzola P; Annoni G
    Curr Aging Sci; 2018; 11(3):195-200. PubMed ID: 30520387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes.
    Haeri NS; Mahmud H; Korytkowski MT
    AACE Clin Case Rep; 2021; 7(6):376-378. PubMed ID: 34765735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia.
    Baxter RC
    Horm Res; 1996; 46(4-5):195-201. PubMed ID: 8950621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review.
    Khowaja A; Johnson-Rabbett B; Bantle J; Moheet A
    BMC Endocr Disord; 2014 Jun; 14():49. PubMed ID: 24934576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
    Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
    Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
    Daughaday WH; Trivedi B; Baxter RC
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH).
    Bertherat J; Logié A; Gicquel C; Mourriéras F; Luton JP; Le Bouc Y
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):213-20. PubMed ID: 10931103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.